These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 34178676)

  • 1. LLGL2 Increases Ca
    Leng S; Xie F; Liu J; Shen J; Quan G; Wen T
    Front Oncol; 2021; 11():683629. PubMed ID: 34178676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. LLGL2 rescues nutrient stress by promoting leucine uptake in ER
    Saito Y; Li L; Coyaud E; Luna A; Sander C; Raught B; Asara JM; Brown M; Muthuswamy SK
    Nature; 2019 May; 569(7755):275-279. PubMed ID: 30996345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of PI3K/AKT is involved in TINAG-mediated promotion of proliferation, invasion and migration of hepatocellular carcinoma.
    Zhang MH; Niu H; Li Z; Huo RT; Wang JM; Liu J
    Cancer Biomark; 2018; 23(1):33-43. PubMed ID: 29991125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long non-coding RNA PTTG3P promotes cell growth and metastasis via up-regulating PTTG1 and activating PI3K/AKT signaling in hepatocellular carcinoma.
    Huang JL; Cao SW; Ou QS; Yang B; Zheng SH; Tang J; Chen J; Hu YW; Zheng L; Wang Q
    Mol Cancer; 2018 May; 17(1):93. PubMed ID: 29803224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SPAG5 interacts with CEP55 and exerts oncogenic activities via PI3K/AKT pathway in hepatocellular carcinoma.
    Yang YF; Zhang MF; Tian QH; Fu J; Yang X; Zhang CZ; Yang H
    Mol Cancer; 2018 Aug; 17(1):117. PubMed ID: 30089483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing of LLGL2 Suppresses the Estradiol-Induced BPH-1 Cell Proliferation through the Regulation of Autophagy.
    Kim KH; Hong GL; Kim YJ; Lee HJ; Jung JY
    Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009528
    [TBL] [Abstract][Full Text] [Related]  

  • 7.
    Gu QY; Liu YX; Wang JL; Huang XL; Li RN; Linghu H
    Cancers (Basel); 2023 Dec; 15(24):. PubMed ID: 38136424
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian Llgl2 is necessary for proper branching morphogenesis during placental development.
    Sripathy S; Lee M; Vasioukhin V
    Mol Cell Biol; 2011 Jul; 31(14):2920-33. PubMed ID: 21606200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sema3d Restrained Hepatocellular Carcinoma Progression Through Inactivating Pi3k/Akt Signaling
    Li Y; Xu C; Sun B; Zhong F; Cao M; Yang L
    Front Oncol; 2022; 12():913498. PubMed ID: 35957887
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CircCCNB1 silencing acting as a miR-106b-5p sponge inhibited GPM6A expression to promote HCC progression by enhancing DYNC1I1 expression and activating the AKT/ERK signaling pathway.
    Liu YM; Cao Y; Zhao PS; Wu LY; Lu YM; Wang YL; Zhao JF; Liu XG
    Int J Biol Sci; 2022; 18(2):637-651. PubMed ID: 35002514
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of nicastrin on hepatocellular carcinoma proliferation and apoptosis through PI3K/AKT signalling pathway modulation.
    Wang X; Wang X; Xu Y; Yan M; Li W; Chen J; Chen T
    Cancer Cell Int; 2020; 20():91. PubMed ID: 32226312
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ADORA1 Promotes Hepatocellular Carcinoma Progression via PI3K/AKT Pathway.
    Ni S; Wei Q; Yang L
    Onco Targets Ther; 2020; 13():12409-12419. PubMed ID: 33293832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MCM6 promotes metastasis of hepatocellular carcinoma via MEK/ERK pathway and serves as a novel serum biomarker for early recurrence.
    Liu M; Hu Q; Tu M; Wang X; Yang Z; Yang G; Luo R
    J Exp Clin Cancer Res; 2018 Jan; 37(1):10. PubMed ID: 29357919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNA-155-5p promotes hepatocellular carcinoma progression by suppressing PTEN through the PI3K/Akt pathway.
    Fu X; Wen H; Jing L; Yang Y; Wang W; Liang X; Nan K; Yao Y; Tian T
    Cancer Sci; 2017 Apr; 108(4):620-631. PubMed ID: 28132399
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-300 regulates the epithelial-mesenchymal transition and invasion of hepatocellular carcinoma by targeting the FAK/PI3K/AKT signaling pathway.
    Wang R; Yu Z; Chen F; Xu H; Shen S; Chen W; Chen L; Su Q; Zhang L; Bi J; Zeng W; Li W; Huang X; Wang Q
    Biomed Pharmacother; 2018 Jul; 103():1632-1642. PubMed ID: 29864952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-1296 inhibits metastasis and epithelial-mesenchymal transition of hepatocellular carcinoma by targeting SRPK1-mediated PI3K/AKT pathway.
    Xu Q; Liu X; Liu Z; Zhou Z; Wang Y; Tu J; Li L; Bao H; Yang L; Tu K
    Mol Cancer; 2017 Jun; 16(1):103. PubMed ID: 28606154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CLCA4 inhibits cell proliferation and invasion of hepatocellular carcinoma by suppressing epithelial-mesenchymal transition via PI3K/AKT signaling.
    Liu Z; Chen M; Xie LK; Liu T; Zou ZW; Li Y; Chen P; Peng X; Ma C; Zhang WJ; Li PD
    Aging (Albany NY); 2018 Oct; 10(10):2570-2584. PubMed ID: 30312171
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-3691-5p promotes hepatocellular carcinoma cell migration and invasion through activating PI3K/Akt signaling by targeting PTEN.
    Du W; Zhang X; Wan Z
    Onco Targets Ther; 2019; 12():4897-4906. PubMed ID: 31417285
    [No Abstract]   [Full Text] [Related]  

  • 19. Increased dopamine and its receptor dopamine receptor D1 promote tumor growth in human hepatocellular carcinoma.
    Yan Y; Pan J; Chen Y; Xing W; Li Q; Wang D; Zhou X; Xie J; Miao C; Yuan Y; Zeng W; Chen D
    Cancer Commun (Lond); 2020 Dec; 40(12):694-710. PubMed ID: 33017522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel lncRNA SFTA1P Promotes Tumor Growth by Down-Regulating miR-4766-5p via PI3K/AKT/mTOR Signaling Pathway in Hepatocellular Carcinoma.
    Huang G; Yang Y; Lv M; Huang T; Zhan X; Kang W; Hou J
    Onco Targets Ther; 2020; 13():9759-9770. PubMed ID: 33061455
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.